Skip to content

TTRX TTRX Total Liabilities & Equity

Total Liabilities & Equity at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$24.5B-7.3%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$91.53M+7.7%
PTH
Pelthos Therapeutics Inc.PTHS
$145.38M+15,855%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$511.25M-30.9%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$460M+33.7%

Other financials

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's total liabilities & equity?
TTRX (TTRX) reported total liabilities & equity of $18.64M in Q1 2026.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.